No profile data available.
Quanterix Corporation (QTRX) is a healthcare company in the biological analysis equipment industry, based in Billerica, United States, with about 450 full-time employees.
It reported revenue of $135.44 million for fiscal year 2024, up 11.8% from fiscal year 2023, and net income of -$38.53 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $40.15 million, up 13.4% from a year before. North America was its largest region in fiscal year 2025, with 61% of revenue. Its market capitalization was $155.12 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Quanterix reported $135.44 million in revenue for fiscal year 2024, up 11.8% from $121.14 million in fiscal year 2023. In Q3 2025 revenue was $40.15 million.
North America: 61% of revenue by region in fiscal year 2025, followed by Europe, Middle East, and Africa (26%).
$155.12 million as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Nautilus Biotechnology, Inc. (NAUT), Standard BioTools Inc. (LAB), Alpha Teknova, Inc. (TKNO), Seer, Inc. (SEER).